Works Cited

1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases (STDs): Data and Statistics. Available at https://www.cdc.gov/std/statistics/default.htm. Last accessed September 12, 2021.

2. Medline Plus. Reportable Diseases. Available at https://medlineplus.gov/ency/article/001929.htm. Last accessed September 12, 2021.

3. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2019. Available at https://www.cdc.gov/std/statistics/2019/default.htm. Last accessed September 12, 2021.

4. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among U.S. women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187-193.

5. California Department of Public Health. California STD Screening Recommendations, 2015. Available at https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/CA_STD-Screening-Recs.pdf. Last accessed September 12, 2021.

6. Centers for Disease Control and Prevention. Gonorrhea: CDC Fact Sheet (Detailed Version). Available at https://www.cdc.gov/std/gonorrhea/stdfact-gonorrhea-detailed.htm. Last accessed September 12, 2021.

7. McAdam AJ, Milner DA, Sharpe AH. Infectious diseases. In: Kumar V, Abbas AK, Aster JC (eds). Robbins and Cotran's Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Elsevier Saunders; 2015.

8. Marrazzo JM, Handsfield HH, Sparling PF. Neisseria gonorrhea. In: Mandel GL, Gordon Douglas R, Bennett JE (eds). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010.

9. Centers for Disease Control and Prevention. Gonorrhea: CDC Fact Sheet. Available at https://www.cdc.gov/std/gonorrhea/stdfact-gonorrhea.htm. Last accessed September 12, 2021.

10. Little JW, Falace DA, Miller CS, Rhodus NL. Little and Falace's Dental Management of the Medically Compromised Patient. 8th ed. St. Louis, MO: Elsevier/Mosby; 2013.

11. Mayor MT, Roett MA, Uduhiri KA. Diagnosis and management of gonococcal infections. Am Fam Physician. 2012;86(10):931-938.

12. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1990. MMWR Morb Mortal Wkly Rep. 1990;39(53):1-61.

13. Miller KE. Diagnosis and treatment of Neisseria gonorrhoeae infections. Am Fam Physician. 2006;73(10):1779-1784.

14. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 24th ed. Hudson, OH: Lexicomp; 2018.

15. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2021. Available at https://www.cdc.gov/std/treatment-guidelines/toc.htm. Last accessed September 12, 2021.

16. Centers for Disease Control and Prevention. Two New Promising Treatment Regimens for Gonorrhea: Additional Options Urgently Needed. Available at https://www.cdc.gov/nchhstp/newsroom/2013/Gonorrhea-Treatment-Trial-PressRelease.html. Last accessed September 12, 2021.

17. Centers for Disease Control and Prevention. Syphilis: CDC Fact Sheet. Available at https://www.cdc.gov/std/syphilis/stdfact-syphilis.htm. Last accessed September 12, 2021.

18. Singh PV, Ranjit R. Atypical oral manifestations in secondary syphilis. Indian J Dent Res. 2013;24(1):142-144.

19. Sanchez MR. Syphilis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (eds). Fitzpatrick's Dermatology in General Medicine. 8th ed. New York, NY: McGraw Hill; 2012.

20. Ficarra G, Carlos R. Syphilis: the renaissance of an old disease with new implications. Head Neck Pathol. 2009;3(3):195-206.

21. Leão JC, Gueiros LA, Porter SR. Oral manifestations of syphilis. Clinics. 2006;61(2):161-166.

22. Hook EW III, Marra CM. Acquired syphilis in adults. New Engl J Med. 1992;326(16):1060-1068.

23. Cohen SE, Klausner JD, Engelman J, Philip S. Syphilis in the modern era: an update for physicians. Infect Dis Clin North Am. 2013;27(4):705-722.

24. Pessoa L, Galvão V. Clinical aspects of congenital syphilis with Hutchinson's triad. BMJ Case Rep. 2011;12:1-3.

25. Hillson S, Grigson C, Bond S. Dental defects of congenital syphilis. Am J Phys Anthopol. 1998;107(1):25-40.

26. Centers for Disease Control and Prevention. HPV Infection. Available at https://www.cdc.gov/hpv/parents/about-hpv.html. Last accessed September 12, 2021.

27. Gargano J, Meites E, Watson M, Unger E, Markowitz L, Centers for Disease Control and Prevention. Manual for Surveillance of Vaccine-Preventable Diseases. Chapter 5: Human Papillomavirus (HPV). Available at https://www.cdc.gov/vaccines/pubs/surv-manual/chpt05-hpv.html. Last accessed September 12, 2021.

28. Syrjänen S. Human papillomavirus infections and oral tumors. Med Microbiol Immunol. 2003;192(3):123-128.

29. Lukes SM, Meneses MB. The dental hygienist's role in HPV recognition. Dimens Dent Hyg. 2010;8(6):72.75-77.

30. University of Washington. Oral Pathology Case of the Month: Condyloma Acuminatum. Available at https://dental.washington.edu/oral-pathology/case-of-the-month-archives/com-jan-2011-diagnosis. Last accessed September 12, 2018.

31. Jackson JL, Muhammad A, Longwe E, Childers Ester LB, Mody V. Condyloma acuminatum: an opportunistic infection found in the oral cavity. New York Medical Journal. 2010;5(2).

32. Weiss A, Dym H. Oral Lesions Caused by the Human Papillomavirus. Available at http://www.clinicaladvisor.com/cmece-features/oral-lesions-caused-by-human-papillomavirus/article/193918. Last accessed September 12, 2021.

33. Fazel N, Wilczynski S, Lowe L, Su LD. Clinical, histopathologic and molecular aspects of cutaneous human papillomavirus infections. Dermatol Clin. 1999;17(3):521-536.

34. Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of the human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(1):K1-K16.

35. Patton L, Glick M. The ADA Practical Guide to Patients with Medical Conditions. 2nd ed. Chichester: Wiley-Blackwell; 2016.

36. Centers for Disease Control and Prevention. HPV and Oropharyngeal Cancer. Available at https://www.cdc.gov/cancer/hpv/basic_info/hpv_oropharyngeal.htm. Last accessed September 12, 2021.

37. National Cancer Institute. Oropharyngeal Cancer Treatment (Adult). Available at https://www.cancer.gov/types/head-and-neck/hp/adult/oropharyngeal-treatment-pdq. Last accessed September 12, 2021.

38. Waldboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol. 1999;189(1):12-19.

39. Centers for Disease Control and Prevention. Human Papillomavirus (HPV) Vaccine. Available at https://www.cdc.gov/vaccinesafety/vaccines/hpv-vaccine.html. Last accessed September 12, 2021.

40. U.S. Food and Drug Administration. Gardasil 9. Available at https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9. Last accessed September 12, 2021.

41. European Society for Medical Oncology. FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by Five Additional Types of HPV. Available at https://www.esmo.org/oncology-news/archive/fda-approves-gardasil-9-for-prevention-of-certain-cancers-caused-by-five-additional-types-of-hpv. Last accessed September 12, 2021.

42. Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7):e68329.

43. Ozden B, Gunduz K, Gunhan O, Ozden FO. A case report of focal epithelial hyperplasia (Heck's disease) with PCR detection of human papillomavirus. J Maxillofac Oral Surg. 2011;10(4):357-360.

44. Centers for Disease Control and Prevention. Epstein-Barr Virus and Infectious Mononucleosis. Available athttps://www.cdc.gov/epstein-barr/index.html. Last accessed September 12, 2021.

45. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004;70(7):1279-1287.

46. Shetty K. Epstein-Barr Virus (EBV) Infectious Mononucleosis (Mono) Workup. Available at https://emedicine.medscape.com/article/222040-workup. Last accessed September 12, 2021.

47. Ónodi-Nagy K, Kinyó Á, Meszes A, Garaczi E, Kemény L, Bata-Csörgő Z. Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization. Allergy Asthma Clin Immunol. 2015;11(1):1.

48. Cade JE. Hairy Leukoplakia. Available at https://emedicine.medscape.com/article/279269-overview. Last accessed September 12, 2021.

49. Centers for Disease Control and Prevention. Genital Herpes. Available at https://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Last accessed September 12, 2021.

50. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA, 2006; 296(8):964-973.

51. Johns Hopkins Medicine. Genital Herpes. Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/herpes-hsv1-and-hsv2/genital-herpes. Last accessed September 12, 2021.

52. Centers for Disease Control and Prevention. 2016 Sexually Transmitted Diseases Surveillance: Chlamydia. Available at https://www.cdc.gov/std/statistics/2019/overview.htm#Chlamydia. Last accessed September 12, 2021.

53. Sexually Transmitted Diseases Guide. Chlamydia. Available at https://www.std-gov.org/stds/chlamydia.htm. Last accessed September 12, 2021.

54. Centers for Disease Control and Prevention. HIV in the United States and Dependent Areas. Available at https://www.cdc.gov/hiv/statistics/overview/ataglance.html. Last accessed September 12, 2021.

55. Joyce MP, Kuhar D, Brooks JT. Notes from the field: occupationally acquired HIV infection among health care workers—United States, 1985–2013. MMWR. 2015;63(53):1245-1246.

56. Centers for Disease Control and Prevention. Occupational HIV Transmission and Prevention Among Health Care Workers. Available at https://www.cdc.gov/hiv/workplace/healthcareworkers.html. Last accessed September 12, 2021.

57. Centers for Disease Control and Prevention. Revised surveillance case definition for HIV infection—United States, 2014. MMWR. 2014;63(RR3):1-10.

58. Vaseliu N, Kamiru H, Kabue M. Oral Manifestations of HIV Infection. Available at https://bipai.org/sites/bipai/files/13-Oral-Manifestations.pdf. Last accessed September 12, 2021.

59. Tyring SK (ed). Mucosal Immunology and Virology. Singapore: Springer-Verlag London Limited; 2006.

60. Dodd CL, Greenspan D, Greenspan JS. Oral Kaposi's sarcoma in a woman as a first indication of HIV infection. J Am Dent Assoc. 1991;122(4):61-63.

61. Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2005;13(5):143-148.

62. Schlecht NF, Masika M, Diaz A, et al. Risk of oral human papillomavirus infection among sexually active female adolescents receiving the quadrivalent vaccine. JAMA Netw Open. 2019;2(10):e1914031.

Evidence-Based Practice Recommendations Citations

1. World Health Organization. WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016. Available at https://www.who.int/reproductivehealth/publications/rtis/gonorrhoea-treatment-guidelines/en. Last accessed September 24, 2021.

2. The U.S. Preventive Services Task Force. Syphilis Infection in Nonpregnant Adults and Adolescents: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-nonpregnant-adults-and-adolescents. Last accessed September 24, 2021.

3. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Washington, DC: Department of Health and Human Services; 2021. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf. Last accessed September 24, 2021.


Copyright © 2021 NetCE, PO Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.